Initial Single-Pill Blood Pressure-Lowering Therapy: Should It Be for Most People? - sprookjes - yvandenbroek - TriplyDB

Initial Single-Pill Blood Pressure-Lowering Therapy: Should It Be for Most People?

Initial Single-Pill Blood Pressure-Lowering Therapy: Should It Be for Most People?

http://www.wikidata.org/entity/Q47131668

about

Initial Single-Pill Blood Pressure-Lowering Therapy: Should It Be for Most People?

http://www.wikidata.org/entity/Q47131668

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Initial Single-Pill Blood Pressure-Lowering Therapy: Should It Be for Most People?

@en

Initial Single-Pill Blood Pressure-Lowering Therapy: Should It Be for Most People?

@nl

type

label

Initial Single-Pill Blood Pressure-Lowering Therapy: Should It Be for Most People?

@en

Initial Single-Pill Blood Pressure-Lowering Therapy: Should It Be for Most People?

@nl

prefLabel

Initial Single-Pill Blood Pressure-Lowering Therapy: Should It Be for Most People?

@en

Initial Single-Pill Blood Pressure-Lowering Therapy: Should It Be for Most People?

@nl

P1433

Q47131668-2B9D53BC-FF0D-497E-8BB5-25DC7DC979AF

P1476

Q47131668-A928D243-1DFB-496A-BF46-15F28E0D546D

P2093

Q47131668-2BB1FD91-A042-4F34-A9B3-EB7EC685C193

Q47131668-70A34536-A416-449E-91A6-2DC423EB45E8

P2860

Q47131668-006B5C88-39BE-4655-94AC-CC60BE7137A3

Q47131668-185B6A48-808F-43E9-A7E5-AA22BCDABA5A

Q47131668-21178133-8B81-4D55-87ED-8364CCC6DF9C

Q47131668-27F3DC21-E644-4F80-878B-00ACC11A8501

Q47131668-2FF008A2-2091-4EAB-AFEA-EEA5A2ACD7E1

Q47131668-43A1EBF9-F8CB-4A13-BA82-26170A151684

Q47131668-4BCD786C-3E80-449B-8007-51EF4F15981C

Q47131668-521998FD-912E-41DA-8CAE-7ACBA4463972

Q47131668-54126CB3-DBB7-431C-A78C-9306C5712E4A

Q47131668-5AFCF769-2856-4DE1-9142-C2A84F60D797

P31

Q47131668-3DDB9B46-D794-4C2B-9211-882787A08EDB

Q47131668-7127145b-ad36-4a1e-a559-1e3bc25e52bf

P356

Q47131668-D1EE1905-6D35-4209-BC5C-A55FF71ECBD8

P433

Q47131668-30F5A5E3-CA68-401E-A26E-B371C11C7A1A

P478

Q47131668-A6FE82D8-2D7E-4C13-A15C-685DFA05D67F

P577

Q47131668-FE198C41-409A-4864-98AC-892D08AB5CB9

P698

Q47131668-E255984B-D3C0-4115-A34C-EA00FB0CE583

P932

Q47131668-2330ACD5-B93C-4EE5-85B1-F75791EAC311

P356

JAHA.117.007760

P1433

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

P1476

Initial Single-Pill Blood Pressure-Lowering Therapy: Should It Be for Most People?

@en

P2093

George L Bakris

http://www.w3.org/2001/XMLSchema#string

Omar Al Dhabyi

http://www.w3.org/2001/XMLSchema#string

P2860

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease.

Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials.

Why most interventions to improve physician prescribing do not seem to work.

Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial.

P31

scholarly article

P356

10.1161/JAHA.117.007760

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29151038

http://www.w3.org/2001/XMLSchema#string

P932

5721807

http://www.w3.org/2001/XMLSchema#string